Chicago/Turabian Style
Kumar, Madalsa. 2022. "Blockchain Technology - A Algorithm for Drug Serialization".
Current Research in Public Health 1, no. 1: 61-67.
https://doi.org/10.31586/ujpp.2022.452
@Article{crph452,
AUTHOR = {Kumar, Madalsa},
TITLE = {Blockchain Technology - A Algorithm for Drug Serialization},
JOURNAL = {Current Research in Public Health},
VOLUME = {1},
YEAR = {2022},
NUMBER = {1},
PAGES = {61-67},
URL = {https://www.scipublications.com/journal/index.php/UJPP/article/view/452},
ISSN = {2831-5162},
DOI = {10.31586/ujpp.2022.452},
ABSTRACT = {The Blockchain technology uses different type of database that transact data in blocks and then chained each data blocks. When data fills one block, it is chained the same data onto previous block therefore, all the data blocks are stored in chronological order. The blockchain technology can help to ensure that data in supply chain is reliable, accurate and can be shared with all stakeholders without any manipulation. It makes supply chain more transparent and end-to-end digital visibility of data source. Blockchain is stringent technology which fill the gap between stakeholders by providing transparent unmanipulated and truthful data in supply chain. There are many initiatives has been taken by multiple regulatory bodies with partnering with supply chain stakeholders including pharmaceutical manufacturer, distributors and dispensers. In USA, Food and Drug Administration’s regulatory body Drug Supply Chain Security Act (DSCSA) initi-ated pilot program in 2019 with the partnership of leading pharmaceuticals distributors to au-thenticating saleable returns to distributor from supply chain partners. DSCSA used MediLedger blockchain interoperable technology for process evaluation and it robustness for mitigating risk of drug counterfeiting possibilities in supply chain. The DSCSA found that pilot project was suc-cessful and results were astonishing. Later it was declared that blockchain technology can also be used for meeting DSCSA’s 2023 Act for unit level traceability.},
}
TY - JOUR
AU - Kumar, Madalsa
TI - Blockchain Technology - A Algorithm for Drug Serialization
T2 - Current Research in Public Health
PY - 2022
VL - 1
IS - 1
SN - 2831-5162
SP - 61
EP - 67
UR - https://www.scipublications.com/journal/index.php/UJPP/article/view/452
AB - The Blockchain technology uses different type of database that transact data in blocks and then chained each data blocks. When data fills one block, it is chained the same data onto previous block therefore, all the data blocks are stored in chronological order. The blockchain technology can help to ensure that data in supply chain is reliable, accurate and can be shared with all stakeholders without any manipulation. It makes supply chain more transparent and end-to-end digital visibility of data source. Blockchain is stringent technology which fill the gap between stakeholders by providing transparent unmanipulated and truthful data in supply chain. There are many initiatives has been taken by multiple regulatory bodies with partnering with supply chain stakeholders including pharmaceutical manufacturer, distributors and dispensers. In USA, Food and Drug Administration’s regulatory body Drug Supply Chain Security Act (DSCSA) initi-ated pilot program in 2019 with the partnership of leading pharmaceuticals distributors to au-thenticating saleable returns to distributor from supply chain partners. DSCSA used MediLedger blockchain interoperable technology for process evaluation and it robustness for mitigating risk of drug counterfeiting possibilities in supply chain. The DSCSA found that pilot project was suc-cessful and results were astonishing. Later it was declared that blockchain technology can also be used for meeting DSCSA’s 2023 Act for unit level traceability.
DO - Blockchain Technology - A Algorithm for Drug Serialization
TI - 10.31586/ujpp.2022.452
ER -